Contract Manufacturing
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
107
NCT02420314
Pharmacological Ascorbate for Lung Cancer
Phase: Phase 2
Role: Collaborator
Start: Apr 30, 2015
Completion: Aug 27, 2022
NCT02534753
A Pharmacokinetics Study of Intravenous Ascorbic Acid
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2015
Completion: Jan 31, 2016
NCT02905578
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
Start: Nov 28, 2018
Completion: Aug 26, 2024
NCT05501548
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
Start: Jun 30, 2023
Completion: Oct 14, 2024
Loading map...